Impairment of leukocyte trafficking in a murine pleuritis model by IL-4 and IL-10

被引:20
作者
Fine, JS [1 ]
Rojas-Triana, A [1 ]
Jackson, JV [1 ]
Engstrom, LW [1 ]
Deno, GS [1 ]
Lundell, DJ [1 ]
Bober, LA [1 ]
机构
[1] Schering Plough Corp, Res Inst, Dept Immunol, Kenilworth, NJ 07033 USA
关键词
chemokine; cytokine; leukocyte trafficking; pleuritis;
D O I
10.1023/A:1025076111950
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have characterized leukocyte migration to the pleural cavity in a methylated-BSA (mBSA)-induced model of murine delayed-type hypersensitivity and evaluated the ability of IL-4 and IL-10 to modulate this response. Neutrophils, macrophages, T cells, and dendritic cells migrated to the pleural cavity in a time-dependent fashion following direct intrapleural antigen challenge, with neutrophils comprising the majority of exudate leukocytes in the cavity within the first 24 h and the number of mononuclear cells increasing at later times. Real-time quantitative PCR analysis of infiltrating leukocytes revealed a marked elevation of steady-state mRNA levels of IL-1beta and TNFalpha and the chemokines KC, MIP-2, CXCL9, CXCL10, CXCL11, CCL2, CCL3, and CCL4 at 6 h postchallenge, which diminished over time. In contrast, gammaIFN mRNA levels were maximal at 24 h and CCL5 expression was sustained throughout 72 h. ELISA analysis of pleural exudate fluid revealed significant elevations of KC and CCL2 protein levels at 6 h postantigen challenge and a peak increase in. IFN protein at 24 h, confirming our mRNA observations. Administration of recombinant murine IL-4 or IL-10 prior to challenge significantly blocked cell trafficking to the pleural cavity as well as peak levels of exudate gammaIFN, with IL-4 being more potent in impairing these responses. IL-4 administration also increased the proportion of naive T cells in the pleural cavity, as judged by CD62L and CD45RB expression. These results indicate that this in vivo model demonstrates a pattern of events associated with Th1-mediated leukocyte trafficking and underscore the potential utility of this in vivo model for evaluating therapeutic inhibitors of leukocyte trafficking.
引用
收藏
页码:161 / 174
页数:14
相关论文
共 39 条
[21]   Chemokines and disease [J].
Gerard, C ;
Rollins, BJ .
NATURE IMMUNOLOGY, 2001, 2 (02) :108-115
[22]  
JUNG TM, 1988, J IMMUNOL, V141, P4110
[23]   3D face modeling from perspective-views and contour-based generic-model [J].
Lee, KS ;
Wong, KH ;
Or, SH ;
Fung, YF .
REAL-TIME IMAGING, 2001, 7 (02) :173-182
[24]  
LEWIS AJ, 1982, J IMMUNOPHARMACOL, V3, P289
[25]   Chemokines and chemokine receptors: Biology and clinical relevance in inflammation and AIDS [J].
Locati, M ;
Murphy, PM .
ANNUAL REVIEW OF MEDICINE, 1999, 50 :425-440
[26]   Chemokines: immunology's high impact factors [J].
Mackay, CR .
NATURE IMMUNOLOGY, 2001, 2 (02) :95-101
[27]   PROPERTIES AND FUNCTIONS OF INTERLEUKIN-10 [J].
MOSMANN, TR .
ADVANCES IN IMMUNOLOGY, VOLUME 56, 1994, 56 :1-26
[28]   EFFECT OF INTERLEUKIN-4 AND INTERLEUKIN-10 ON LEUKOCYTE MIGRATION AND NITRIC-OXIDE PRODUCTION IN THE MOUSE [J].
PERRETTI, M ;
SZABO, C ;
THIEMERMANN, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 (04) :2251-2257
[29]   TUMOR-NECROSIS-FACTOR IS A CRITICAL MEDIATOR IN HAPTEN-INDUCED IRRITANT AND CONTACT HYPERSENSITIVITY REACTIONS [J].
PIGUET, PF ;
GRAU, GE ;
HAUSER, C ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (03) :673-679
[30]   INTERLEUKIN-4 AND INTERLEUKIN-10 SYNERGIZE TO INHIBIT CELL-MEDIATED-IMMUNITY IN-VIVO [J].
POWRIE, F ;
MENON, S ;
COFFMAN, RL .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) :2223-2229